Zura Bio Limited
ZURA
$1.21
-$0.05-3.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 83.45% | 66.16% | 113.60% | 9.60% | 68.82% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 129.79% | 45.30% | 89.64% | -65.32% | 8.55% |
| Operating Income | -129.79% | -45.30% | -89.64% | 65.32% | -8.55% |
| Income Before Tax | -125.15% | -60.80% | -150.33% | 69.64% | 20.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -125.15% | -60.80% | -150.33% | 69.64% | 20.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -125.15% | -60.80% | -150.33% | 69.64% | 19.23% |
| EBIT | -129.79% | -45.30% | -89.64% | 65.32% | -8.55% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1,102.56% | 25.41% | -48.92% | 87.09% | 99.43% |
| Normalized Basic EPS | -13.66% | 16.87% | -34.27% | 86.11% | 91.88% |
| EPS Diluted | -1,102.56% | 25.41% | -48.92% | 87.09% | 99.43% |
| Normalized Diluted EPS | -13.66% | 16.87% | -34.27% | 86.11% | 91.88% |
| Average Basic Shares Outstanding | 98.16% | 93.31% | 86.31% | 118.49% | 1,220.83% |
| Average Diluted Shares Outstanding | 98.16% | 93.31% | 86.31% | 118.49% | 1,220.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |